Gossamer Bio
GOSS
GOSS
122 hedge funds and large institutions have $513M invested in Gossamer Bio in 2020 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 47 increasing their positions, 31 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
3.3% less ownership
Funds ownership: 73.24% → 69.95% (-3.3%)
14% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 22
25% less capital invested
Capital invested by funds: $684M → $513M (-$171M)
Holders
122
Holding in Top 10
2
Calls
$5.96M
Puts
$1.85M
Top Buyers
| 1 | +$14M | |
| 2 | +$6.69M | |
| 3 | +$6.4M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.26M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$5.8M |
Top Sellers
| 1 | -$42.8M | |
| 2 | -$22M | |
| 3 | -$20.9M | |
| 4 |
MCM
Masters Capital Management
Atlanta,
Georgia
|
-$8.69M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$6.15M |